Correlation Between Aerovate Therapeutics and 459506AQ4

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and 459506AQ4 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and 459506AQ4 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and IFF 23 01 NOV 30, you can compare the effects of market volatilities on Aerovate Therapeutics and 459506AQ4 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of 459506AQ4. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and 459506AQ4.

Diversification Opportunities for Aerovate Therapeutics and 459506AQ4

-0.27

Correlation Coefficient

Aerovate Therapeutics  459506AQ4

Very good diversification

The 3 months correlation between Aerovate and 459506AQ4 is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and IFF 23 01 NOV 30 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IFF 23 01 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with 459506AQ4. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IFF 23 01 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and 459506AQ4 go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and 459506AQ4

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the 459506AQ4. In addition to that, Aerovate Therapeutics is 2.22 times more volatile than IFF 23 01 NOV 30. It trades about -0.04 of its total potential returns per unit of risk. IFF 23 01 NOV 30 is currently generating about -0.01 per unit of volatility. If you would invest  8,515  in IFF 23 01 NOV 30 on December 30, 2024 and sell it today you would lose (59.00) from holding IFF 23 01 NOV 30 or give up 0.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.16%
Values	Daily Returns

Aerovate Therapeutics  vs.  IFF 23 01 NOV 30

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

IFF 23 01

Risk-Adjusted Performance

Very Weak

Over the last 90 days IFF 23 01 NOV 30 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 459506AQ4 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Aerovate Therapeutics and 459506AQ4

The main advantage of trading using opposite Aerovate Therapeutics and 459506AQ4 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, 459506AQ4 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 459506AQ4 will offset losses from the drop in 459506AQ4's long position.

The idea behind Aerovate Therapeutics and IFF 23 01 NOV 30 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.